Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zenas Biopharma Inc shares valued at $166,750 were purchased by MOULDER LEON O JR on Feb 18 ’25. At $6.67 per share, MOULDER LEON O JR acquired 25,000 shares. The insider’s holdings grew to 266,155 shares worth approximately $2.48 million following the completion of this transaction.
Also, Xiao Ting purchased 10,000 shares, netting a total of over 77,600 in proceeds. Following the buying of shares at $7.76 each, the insider now holds 47,000 shares.
Before that, MOULDER LEON O JR had added 45,000 shares to its account. In a trade valued at $449,100, the Chief Executive Officer bought Zenas Biopharma Inc shares for $9.98 each. Upon closing the transaction, the insider’s holdings increased to 45,000 shares, worth approximately $2.25 million.
As published in their initiating research note from Wedbush on March 20, 2025, Zenas Biopharma Inc [ZBIO] has been an Outperform and the price target has been revised to $35. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 16, 2024, H.C. Wainwright has initiated its “Buy” rating for ZBIO. Earlier on November 05, 2024, Rodman & Renshaw initiated its rating. Their recommendation was “a Buy” for ZBIO stock.
Analyzing ZBIO Stock Performance
On last trading session,, Zenas Biopharma Inc [NASDAQ: ZBIO] plunged -3.82% to $9.31. The stock’s lowest price that day was $9.1788, but it reached a high of $9.76 in the same session. During the last five days, there has been a drop of approximately -23.12%. Over the course of the year, Zenas Biopharma Inc shares have jumped approximately 13.68%.
Support And Resistance Levels for Zenas Biopharma Inc (ZBIO)
According to the 24-hour chart, there is a support level at 9.02, which, if violated, would cause prices to drop to 8.73. In the upper region, resistance lies at 9.68. The next price resistance is at 10.05. RSI (Relative Strength Index) is 43.03 on the 14-day chart, showing neutral technical sentiment.
Is Zenas Biopharma Inc subject to short interest?
Stocks of Zenas Biopharma Inc saw a sharp steep in short interest on 2025-05-30 dropping by 12199.0 shares to 4.86 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 4.87 million shares. A decline of -0.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 36.23 of the overall float, the days-to-cover ratio (short ratio) decline to 36.23.
Which companies own the most shares of Zenas Biopharma Inc (ZBIO)?
In terms of Zenas Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 35 in the next 12 months, up nearly 261.57% from the previous closing price of $9.68. Analysts anticipate Zenas Biopharma Inc stock to reach 35 by 2025, with the lowest price target being 35. On October 08, 2024, Morgan Stanley assigned a price target of “an Overweight” to the stock and initiated coverage with a $40.
